Location History:
- Tuebingen, DE (2011)
- Teubingen, DE (2013)
Company Filing History:
Years Active: 2011-2013
Title: Friedrich Asmus: Innovator in Neurodegenerative Disorder Research
Introduction
Friedrich Asmus is a notable inventor based in Teubingen, Germany. He has made significant contributions to the field of neurodegenerative disorders through his innovative research and discoveries. With a total of two patents to his name, Asmus is recognized for his work on the KASPP (LRRK2) gene.
Latest Patents
Asmus's latest patents focus on the KASPP (LRRK2) gene, which is crucial for the detection and treatment of various neurodegenerative disorders. This invention refers to a newly discovered gene named KASPP, which stands for Kinase Associated with Parkinsonism with Pleiomorphic Pathology, or alternatively named LRRK2, which stands for Leucine-Rich Repeat Kinase 2. The patent details the gene's production, biochemical characterization, and its application in detecting and treating disorders such as Parkinson's disease, Alzheimer's disease, amyotrophic lateral sclerosis, and other related conditions. The research also highlights several polymorphisms and mutations in the KASPP/LRRK2 gene that are associated with Parkinson's disease.
Career Highlights
Friedrich Asmus has worked with prestigious institutions, including Eberhard Karls Universität Tübingen and the Mayo Foundation for Medical Education and Research. His career is marked by a commitment to advancing the understanding of neurodegenerative diseases through innovative research.
Collaborations
Asmus has collaborated with notable colleagues in his field, including Thomas Meitinger and Tim Matthias Strom. Their joint efforts have contributed to the advancement of research in neurodegenerative disorders.
Conclusion
Friedrich Asmus is a prominent inventor whose work on the KASPP (LRRK2) gene has the potential to significantly impact the detection and treatment of neurodegenerative disorders. His contributions to the field are invaluable and continue to inspire further research and innovation.